the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements. As such, the Zacks rating upgrade for Rigel is ...
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer ...
In the press release titled “Rigel Provides Business Update and 2025 Outlook,” Rigel Pharmaceuticals shared some significant financial highlights. For the fourth quarter of 2024, the company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback